Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory MechanismAlexander Duscha, Aiden Haghikia, Riccardo Troisi et al.|Cell|2020Cited by 627
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trialLudwig Kappos, Paul D. Crowe, Giancarlo Comi et al.|Nature Medicine|2000Cited by 515
Increased susceptibility to sporadic Parkinson's disease by a certain combined ?-synuclein/apolipoprotein E genotypeRejko Kr�ger, Olaf Rieß, Ana Vieira‐Saecker et al.|Annals of Neurology|1999Cited by 279
Mutation analysis and association studies of the UCHL1 gene in German Parkinsonʼs disease patientsPhilip Wintermeyer, Olaf Rieß, Rejko Krüger et al.|Neuroreport|2000Cited by 143
Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson’s DiseaseTobias Hegelmaier, Aiden Haghikia, Marco Lebbing et al.|Cells|2020Cited by 114